Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390191 | SCV001591828 | pathogenic | Mowat-Wilson syndrome | 2020-12-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr232*) in the ZEB2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ZEB2 are known to be pathogenic (PMID: 16053902). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This nonsense change has been observed in individual(s) with Mowat-Wilson syndrome (PMID: 16053902, 27831545, 28501473). |